Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
7
×
allergan
7
×
biotech
clinical trials
fda
life sciences
national blog main
boston blog main
national top stories
boston top stories
eli lilly
europe blog main
national
new york blog main
san francisco blog main
boulder/denver blog main
boulder/denver top stories
crispr
detroit blog main
detroit top stories
europe top stories
indiana blog main
indiana top stories
ipo
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
amgen
astrazeneca
biogen
What
fda
bio
medicines
roundup
treatment
biotech
new
won
abbvie
acquisitions
adults
alkermes
allergan
alliance
announced
antipsychotic
approved
approves
august
benefit
benefits
black
busy
caveats
ceo
class
collabs
commonly
companies
continue
covid
daniel
days
deal
debut
decisions
designed
devices
diamond
diamond’s
Language
unset
Current search:
allergan
×
abbvie
×
@extremetech.com
2 years ago
FDA Approves New Eye Drops that Could Replace Glasses for Millions
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More